These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 17884023

  • 1. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
    Boyd JD, Jang H, Shepherd KR, Faherty C, Slack S, Jiao Y, Smeyne RJ.
    Brain Res; 2007 Oct 17; 1175():107-16. PubMed ID: 17884023
    [Abstract] [Full Text] [Related]

  • 2. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
    Wang Y, Zhang Y, Wei Z, Li H, Zhou H, Zhang Z, Zhang Z.
    J Neurol Sci; 2009 Oct 15; 285(1-2):172-7. PubMed ID: 19604516
    [Abstract] [Full Text] [Related]

  • 3. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 15; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 4. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
    Wang YS, Zhou JP, Wei ZF, Tian QY, Zhou HX, Zhang YX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug 15; 27(8):1199-202, 1205. PubMed ID: 17715026
    [Abstract] [Full Text] [Related]

  • 5. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Hayley S, Crocker SJ, Smith PD, Shree T, Jackson-Lewis V, Przedborski S, Mount M, Slack R, Anisman H, Park DS.
    J Neurosci; 2004 Feb 25; 24(8):2045-53. PubMed ID: 14985447
    [Abstract] [Full Text] [Related]

  • 6. Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway.
    Yu S, Zheng W, Xin N, Chi ZH, Wang NQ, Nie YX, Feng WY, Wang ZY.
    Rejuvenation Res; 2010 Feb 25; 13(1):55-64. PubMed ID: 20230279
    [Abstract] [Full Text] [Related]

  • 7. Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Ye Q, Yuan X, Zhou J, Yuan C, Yang X.
    J Tradit Chin Med; 2017 Apr 25; 37(2):244-51. PubMed ID: 29960635
    [Abstract] [Full Text] [Related]

  • 8. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
    Karunakaran S, Diwakar L, Saeed U, Agarwal V, Ramakrishnan S, Iyengar S, Ravindranath V.
    FASEB J; 2007 Jul 25; 21(9):2226-36. PubMed ID: 17369508
    [Abstract] [Full Text] [Related]

  • 9. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.
    Pattarini R, Smeyne RJ, Morgan JI.
    Neuroscience; 2007 Mar 16; 145(2):654-68. PubMed ID: 17258864
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
    Teng X, Sakai T, Liu L, Sakai R, Kaji R, Fukui K.
    J Neurochem; 2006 May 16; 97(4):1126-35. PubMed ID: 16686692
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of the c-Jun N terminal kinase pathway in an animal model of Parkinson's disease.
    Willesen MG, Gammeltoft S, Vaudano E.
    Ann N Y Acad Sci; 2002 Nov 16; 973():237-40. PubMed ID: 12485868
    [Abstract] [Full Text] [Related]

  • 15. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
    Castro-Caldas M, Carvalho AN, Rodrigues E, Henderson CJ, Wolf CR, Rodrigues CM, Gama MJ.
    Mol Neurobiol; 2012 Oct 16; 46(2):475-86. PubMed ID: 22773138
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.